MedPath
NMPA Approval

Dacarbazine for Injection

国药准字H20043620

August 25, 2020

Drug Information

注射用达卡巴嗪

注射剂

0.2g

化学药品

August 25, 2020

Company Information

Applicant Company

Manufacturing Company

山西省大同经济技术开发区第一医药园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用达卡巴嗪 - NMPA 批准文号 | MedPath